Open access
Open access
Powered by Google Translator Translator

Psychiatry

Anxiety in the medically ill: a systematic review of the literature.

22 Jun, 2022 | 11:05h | UTC

Anxiety in the Medically Ill: A Systematic Review of the Literature – Frontiers in Psychology

 


Systematic Review: Music therapy for people with substance use disorders.

22 Jun, 2022 | 11:02h | UTC

Music therapy for people with substance use disorders – Cochrane Library

Summary: Music therapy for people with substance use disorder – Cochrane Library

 


RCT: Guided, internet based, cognitive behavioral therapy noninferior to individual face-to-face CBT for patients with post-traumatic stress disorder.

21 Jun, 2022 | 11:06h | UTC

Guided, internet based, cognitive behavioural therapy for post-traumatic stress disorder: pragmatic, multicentre, randomised controlled non-inferiority trial (RAPID) – The BMJ

 


Cohort Study: Association of obsessive-compulsive disorder and obsessive-compulsive symptoms with substance misuse.

21 Jun, 2022 | 10:42h | UTC

Association of Obsessive-Compulsive Disorder and Obsessive-Compulsive Symptoms With Substance Misuse in 2 Longitudinal Cohorts in Sweden – JAMA Network Open

 

Commentary on Twitter

 


Cluster RCT: Evaluation of a multicomponent intervention consisting of education and feedback to reduce benzodiazepine prescriptions by general practitioners.

21 Jun, 2022 | 10:29h | UTC

Evaluation of a multicomponent intervention consisting of education and feedback to reduce benzodiazepine prescriptions by general practitioners: The BENZORED hybrid type 1 cluster randomized controlled trial – PLOS One

 


WHO report highlights urgent need to transform mental health and mental health care.

20 Jun, 2022 | 10:47h | UTC

News Release: WHO highlights urgent need to transform mental health and mental health care – World Health Organization

Report: World mental health report: Transforming mental health for all – World Health Organization

Commentary: Urgent Need to Transform Mental Health Care – WHO Says In Largest Review Ever – Health Policy Watch

 

Commentary on Twitter (thread – click for more)

 


Cohort Study: Long-term risk of overdose or mental health crisis after opioid dose tapering.

14 Jun, 2022 | 10:53h | UTC

Long-term Risk of Overdose or Mental Health Crisis After Opioid Dose Tapering – JAMA Network Open

Editorial: New Data on Opioid Dose Reduction—Implications for Patient Safety – JAMA Network Open

News Release: Increased overdose and mental health risks persist two years after opioid dose reduction –  UC Davis Center for Healthcare Policy and Research

 


Systematic Review: Impact of vision impairment and ocular morbidity and their treatment on depression and anxiety in children.

14 Jun, 2022 | 10:34h | UTC

Impact of vision impairment and ocular morbidity and their treatment on depression and anxiety in children: A systematic review – Ophthalmology

Commentary: Vision Impairment Associated with Greater Depression, Anxiety in Children – HCP Live

 


Opioid-sparing effect of cannabinoids for analgesia: an updated systematic review and meta-analysis of preclinical and clinical studies.

14 Jun, 2022 | 10:30h | UTC

Opioid-sparing effect of cannabinoids for analgesia: an updated systematic review and meta-analysis of preclinical and clinical studies – Neuropsychopharmacology

 

Commentary on Twitter

 


Brief Review: Mental health morbidity, self-harm, and suicide in ICU survivors and caregivers.

13 Jun, 2022 | 08:01h | UTC

Mental health morbidity, self-harm, and suicide in ICU survivors and caregivers – Intensive Care Medicine (if the link is paywalled, try this one)

 

Commentary on Twitter

 


Study: Most males who die by suicide have no known mental health condition.

13 Jun, 2022 | 07:48h | UTC

Commentary: Most Males Who Die by Suicide Have No Known Mental Health Condition – Psychiatric News Alert

Original study: Suicide Among Males Across the Lifespan: An Analysis of Differences by Known Mental Health Status – American Journal of Preventive Medicine

 


Cohort Study: Long-term outcomes of early use of long-acting injectable antipsychotics in schizophrenia.

13 Jun, 2022 | 07:46h | UTC

Long-term Outcomes of Early Use of Long-Acting Injectable Antipsychotics in Schizophrenia – The Journal of Clinical Psychiatry (link to abstract – $ for full-text)

Commentary: Patients With Schizophrenia Switched Early to LAIs Show Markedly Better Long-Term Outcomes – Psychiatric News Alert

Related:

Comparative efficacy and tolerability of 32 oral and long-acting injectable antipsychotics for the maintenance treatment of adults with schizophrenia: a systematic review and network meta-analysis – The Lancet (link to abstract – $ for full-text)

Long-acting injectable versus oral antipsychotics for the maintenance treatment of schizophrenia: a systematic review and comparative meta-analysis of randomised, cohort, and pre–post studies – The Lancet Psychiatry (link to abstract – $ for full-text)

Long-acting injectable versus oral antipsychotics for the maintenance treatment of schizophrenia: a systematic review and comparative meta-analysis of randomised, cohort, and pre–post studies – The Lancet Psychiatry (link to abstract – $ for full-text)

Effect of Long-Acting Injectable Antipsychotics vs Usual Care on Time to First Hospitalization in Early-Phase Schizophrenia: A Randomized Clinical Trial – JAMA Psychiatry

 


Association of stress-related disorders with subsequent risk of all-cause and cause-specific mortality: A population-based and sibling-controlled cohort study.

10 Jun, 2022 | 11:12h | UTC

Association of stress-related disorders with subsequent risk of all-cause and cause-specific mortality: A population-based and sibling-controlled cohort study – The Lancet Regional Health Europe

Related:

Mental Stress and Its Effects on Vascular Health – Mayo Clinic Proceedings

Association of the 2020 US Presidential Election With Hospitalizations for Acute Cardiovascular Conditions – JAMA Network Open

Psychological Stress and Heart Disease: Fact or Folklore? – The American Journal of Medicine

Sudden Cardiac Death Triggered by an Earthquake – New England Journal of Medicine

Cardiovascular Events during World Cup Soccer – New England Journal of Medicine

 


Meta-Analysis: Prevalence of depression among caregivers of cancer patients.

10 Jun, 2022 | 10:33h | UTC

Systematic Review and Meta-Analysis of Prevalence of Depression Among Caregivers of Cancer Patients – Frontiers in Psychiatry

 


The global landscape of the burden of depressive symptoms/major depression in individuals living with HIV/AIDs and its effect on antiretroviral medication adherence.

10 Jun, 2022 | 10:31h | UTC

The Global Landscape of the Burden of Depressive Symptoms/Major Depression in Individuals Living With HIV/AIDs and Its Effect on Antiretroviral Medication Adherence: An Umbrella Review – Frontiers in Psychiatry

 


Systematic Review: Cannabis-based products for chronic pain.

7 Jun, 2022 | 11:47h | UTC

Cannabis-Based Products for Chronic Pain: A Systematic Review – Annals of Internal Medicine

Annals Video Summary: Cannabis-Based Products for Chronic Pain: A Systematic Review

Summary for Patients: Cannabis-Based Products for Chronic Pain

Related:

Podcast: #338 LIVE! Medical Cannabis: Is it still dope? – The Curbsiders

Medicinal Cannabis for Chronic Pain: The Bermuda Triangle of Low Quality Studies, Countless Meta-analyses and Conflicting Recommendations – European Journal of Pain

RCT: Effect of medical marijuana card ownership on pain, insomnia, and affective disorder symptoms in adults.

Cohort Study: Long-term cannabis use is associated with cognitive deficits and smaller hippocampal volume in midlife.

AHA Scientific Statement | How does cannabis use affect brain health? Caution advised, more research needed.

M-A: Birth outcomes of neonates exposed to marijuana in utero.

Cannabis-related allergies: an international overview and consensus recommendations.

Review: Cannabis-based medicines and medical cannabis for chronic neuropathic pain.

Cannabinoid metabolites as inhibitors of major hepatic CYP450 enzymes, with implications for cannabis-drug interactions.

Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain.

The International Cannabis Toolkit (iCannToolkit): a multidisciplinary expert consensus on minimum standards for measuring cannabis use.

Cannabis products are being sold as sleep remedies – here’s the evidence about their effectiveness.

Guideline: Medical cannabis or cannabinoids for chronic pain.

Cannabis and Cannabinoid Analgesia position statement – “Due to the lack of high-quality clinical evidence, the IASP does not currently endorse general use of cannabis and cannabinoids for pain relief.”

NICE Guideline: Cannabis-Based Medicinal Products

Consensus recommendations for perioperative management of cannabis and cannabinoid-based medicine users

Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain – Agency for Healthcare Research and Quality

Short Review: Drug Interactions with Cannabinoids

Meta-Analysis: Cannabinoids Not Effective for Cancer-Related Pain

Review: Considerations for cannabinoids in perioperative care by anesthesiologists.

Review: Cannabis-based Medicines and the Perioperative Physician

Study: Cannabis Use Disorder May Increase the Risk of Cardiovascular Events in Major Elective Surgeries

Perspective: If You Smoke Pot, Your Anesthesiologist Needs To Know

Perioperative Care of Cannabis Users: A Comprehensive Review of Pharmacological and Anesthetic Considerations

 


M-A: How do income changes impact on mental health and wellbeing for working-age adults?

7 Jun, 2022 | 11:21h | UTC

How do income changes impact on mental health and wellbeing for working-age adults? A systematic review and meta-analysis – The Lancet Public Health – The Lancet Public Health

Invited commentary: The impact of income on mental health

 

Commentary from the author on Twitter (thread – click for more)

 


M-A: The prevalence of comorbid serious mental illnesses and substance use disorders in prison populations.

7 Jun, 2022 | 11:20h | UTC

The prevalence of comorbid serious mental illnesses and substance use disorders in prison populations: a systematic review and meta-analysis – The Lancet Public Health

Invited Commentary: The prevalence of comorbid substance use disorders and serious mental illnesses in prisons

 


Efficacy of neurostimulation across mental disorders: systematic review and meta-analysis of 208 randomized controlled trials.

6 Jun, 2022 | 10:53h | UTC

Efficacy of neurostimulation across mental disorders: systematic review and meta-analysis of 208 randomized controlled trials – Molecular Psychiatry

 


RCTs: Efficacy, safety, and tolerability of Centanafadine sustained-release tablets in adults with attention-deficit/hyperactivity disorder.

3 Jun, 2022 | 11:21h | UTC

Efficacy, Safety, and Tolerability of Centanafadine Sustained-Release Tablets in Adults With Attention-Deficit/Hyperactivity Disorder: Results of 2 Phase 3, Randomized, Double-blind, Multicenter, Placebo-Controlled Trials – Journal of Clinical Psychopharmacology

 


AAP Policy Statement: Recommended terminology for substance use disorders in the care of children, adolescents, young adults, and families.

2 Jun, 2022 | 11:00h | UTC

Recommended Terminology for Substance Use Disorders in the Care of Children, Adolescents, Young Adults, and Families – Pediatrics

 

Commentary from one of the authors on Twitter (thread – click for more)

 


M-A: Antidepressants in children and adolescents with major depressive disorder and the influence of placebo response.

2 Jun, 2022 | 10:32h | UTC

Antidepressants in children and adolescents with major depressive disorder and the influence of placebo response: A meta-analysis – Journal of Affective Disorders (link to abstract – $ for full-text)

Commentaries:

Antidepressants Have Small Effect Sizes for the Treatment of Major Depressive Disorder Among Children – Psychiatry Advisor

Antidepressant Effect Sizes Modest for Pediatric Major Depressive Disorder – Consultant360

 

Commentary on Twitter

 


Cohort Study: Evaluation of neurologic and psychiatric outcomes after hospital discharge among adult survivors of cardiac arrest.

2 Jun, 2022 | 10:15h | UTC

Evaluation of Neurologic and Psychiatric Outcomes After Hospital Discharge Among Adult Survivors of Cardiac Arrest – JAMA Network Open

 


M-A: Prevalence and correlates of suicide and nonsuicidal self-injury in children.

31 May, 2022 | 10:48h | UTC

Prevalence and Correlates of Suicide and Nonsuicidal Self-injury in Children: A Systematic Review and Meta-analysis – JAMA Psychiatry (link to abstract – $ for full-text)

 

Commentary on Twitter

 


Cohort Study: Analysis of neuropsychiatric diagnoses after montelukast initiation.

25 May, 2022 | 11:05h | UTC

Analysis of Neuropsychiatric Diagnoses After Montelukast Initiation – JAMA Network Open

Related:

FDA requires Boxed Warning about serious mental health side effects for asthma and allergy drug montelukast (Singulair); advises restricting use for allergic rhinitis – U.S. Food & Drug Administration

Adverse drug reactions of montelukast in children and adults – Pharmacology Research & Perspectives

 

Commentary on Twitter

 


Stay Updated in Your Specialty

No spam, just news.